Kimberley Doucette

Chemotherapy-free treatment with inotuzumab ozogamicin and blinatumomab for older adults with newly diagnosed, Ph-negative, CD22-positive, B-cell acute lymphoblastic leukemia: Alliance A041703.

Matthew J. Wieduwilt, Jun Yin, Oudom Kour et al. · Journal of Clinical Oncology · 2023 · 48 citations

Medicine, Hematology, Oncology +13

Hypoalbuminemia as a prognostic biomarker for higher mortality and treatment complications in acute myeloid leukemia

Kimberley Doucette, Mary-Elizabeth Percival, Lacey Williams et al. · Hematological Oncology · 2021 · 32 citations

Medicine, Hematology, Oncology +15

Treatment of refractory delayed onset heparin‐induced thrombocytopenia after thoracic endovascular aortic repair with intravenous immunoglobulin (IVIG)

Kimberley Doucette, Christin B. DeStefano, Natasha A. Jain et al. · Research and Practice in Thrombosis and Haemostasis · 2017 · 23 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Efficacy and Safety of Direct-Acting Oral Anticoagulants (DOACs) in the Overweight and Obese

Kimberley Doucette, Hira Latif, Anusha Vakiti et al. · Advances in Hematology · 2020 · 16 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Hospital facility characteristics and socioeconomic factors on outcomes and treatment in patients with multiple myeloma: National Cancer Database analysis

Kimberley Doucette, Allison O. Taylor, Bryan Chan et al. · Annals of Hematology · 2023 · 10 citations

Medicine, Health Services Administration, Oncology +17